Search Within

Maxine Jochelson

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (7)
Groups
  1. Epidemiology and Biostatistics (51)
  2. Molecular Imaging and Therapy Service (51)
  3. Radiology, Department of (51)
  4. Biostatistics Service (32)
  5. Population Sciences Research Program (23)
  6. Body Imaging Service (21)

More Groups

People
  1. Gary Ulaner (16)
  2. Janice Sung (15)
  3. Clifford Hudis (14)
  4. Elizabeth Morris (14)
  5. Srinivasa Sevilimedu Veeravalli (14)
  6. Chaya Moskowitz (12)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (4)
  6. 2020 (2)

More Years

Publications
  1. Radiology (7)
  2. American Journal of Roentgenology (4)
  3. European Journal of Radiology (4)
  4. Journal of Clinical Oncology (4)
  5. Breast Journal (3)
  6. European Journal of Nuclear Medicine and Molecular Imaging (3)

More Publications

Publishers
  1. Springer (8)
  2. Radiological Society of North America, Inc. (7)
  3. Wiley Blackwell (5)
  4. American Roentgen Ray Society (4)
  5. American Society of Clinical Oncology (4)
  6. Oxford University Press (4)

More Publishers

Results (51)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study
    Journal Article

    Jochelson, M. S.; Pinker, K.; Dershaw, D. D.; Hughes, M.; Gibbons, G. F.; Rahbar, K.; Robson, M. E.; Mangino, D. A.; Goldman, D.; Moskowitz, C. S.; more...
    European Journal of Radiology (2017)

    Fulltext@MSK | Save
  • Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
    Journal Article

    Riedl, C. C.; Pinker, K.; Ulaner, G. A.; Ong, L. T.; Baltzer, P.; Jochelson, M. S.; McArthur, H. L.; Gönen, M.; Dickler, M.; Weber, W. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2017)

    Fulltext@MSK | Save
  • Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
    Journal Article

    Krammer, J.; Pinker-Domenig, K.; Robson, M. E.; Gönen, M.; Bernard-Davila, B.; Morris, E. A.; Mangino, D. A.; Jochelson, M. S.
    Breast Cancer Research and Treatment (2017)

    Fulltext@MSK | Save
  • Do calcifications seen on mammography after neoadjuvant chemotherapy for breast cancer always need to be excised?
    Journal Article

    Feliciano, Y.; Mamtani, A.; Morrow, M.; Stempel, M. M.; Patil, S.; Jochelson, M. S.
    Annals of Surgical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Comparison of background parenchymal enhancement at contrast-enhanced spectral mammography and breast MR imaging
    Journal Article

    Sogani, J.; Morris, E. A.; Kaplan, J. B.; D'Alessio, D.; Goldman, D.; Moskowitz, C. S.; Jochelson, M. S.
    Radiology (2017)

    Fulltext@MSK | Save
  • Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients
    Journal Article

    Marinelli, B.; Espinet-Col, C.; Ulaner, G. A.; McArthur, H. L.; Gonen, M.; Jochelson, M.; Weber, W. A.
    American Journal of Nuclear Medicine and Molecular Imaging (2016)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save